A study led by cabinet at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of tincture ( NEJM ), the new findings offer the occurrence of a highly touch-and-go and noteworthy means of identifying this life- minatory riff at an early stage, when it can be treated with by implanting a cardiac defibrillator.

More: - From the site